Dr. Bernard Le Foll, MD
Claim this profileCenter for Addiction and Mental Health
Studies Substance Use Disorder
Studies Methamphetamine Abuse
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Bernard Le Foll, MD is currently running
Cytisine
for Smoking Cessation
The goal of this clinical trial is to evaluate the safety and effectiveness of cytisine as a smoking cessation treatment in individuals with concurrent alcohol use disorder.
Recruiting2 awards Phase 48 criteria
Lisdexamfetamine + Contingency Management
for Methamphetamine Addiction
The goal of this clinical trial is to learn if administering a high dose stimulant with Contingency Management reduces days of use in adults who use methamphetamine better than the usual treatment provided by the clinic. The main questions the trial aims to answer are: Is a high dose stimulant better than a placebo and usual treatment at helping reduce the number of days they use methamphetamine? Is a high dose stimulant with contingency management better than placebo and usual treatment at helping people reduce the number of days they use methamphetamine? Participants will be placed randomly into one of four groups: 1. Usual treatment and placebo 2. Usual treatment, placebo and contingency management 3. Usual treatment and high dose stimulant 4. Usual treatment, high dose stimulant and contingency management Participation includes the following: 1. Participants will receive medication or placebo weekly for 15 weeks. 2. Participants will attend the clinic for weekly treatment 3. Participants will attend the clinic once every 2 weeks for study visits. Each visit will take about an hour to complete. At these visits, participants will be asked to provide a urine sample and complete questionnaires.
Recruiting0 awards Phase 22 criteria
More about Bernard Le Foll, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Bernard Le Foll, MD has experience with
- Placebo
- Cannabis Edibles
- Acceptance Commitment Therapy
- Lisdexamfetamine
- Cannabis
- BP1.3656
Breakdown of trials Bernard Le Foll, MD has run
Substance Use Disorder
Methamphetamine Abuse
Methamphetamine Addiction
Alcohol Consumption
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bernard Le Foll, MD specialize in?
Bernard Le Foll, MD focuses on Substance Use Disorder and Methamphetamine Abuse. In particular, much of their work with Substance Use Disorder has involved treating patients, or patients who are undergoing treatment.
Is Bernard Le Foll, MD currently recruiting for clinical trials?
Yes, Bernard Le Foll, MD is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Bernard Le Foll, MD has studied deeply?
Yes, Bernard Le Foll, MD has studied treatments such as Placebo, Cannabis Edibles, Acceptance Commitment Therapy.
What is the best way to schedule an appointment with Bernard Le Foll, MD?
Apply for one of the trials that Bernard Le Foll, MD is conducting.
What is the office address of Bernard Le Foll, MD?
The office of Bernard Le Foll, MD is located at: Center for Addiction and Mental Health, Toronto, Ontario M6J 1HN Canada. This is the address for their practice at the Center for Addiction and Mental Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.